Cargando…
FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
Adipocyte fatty acid‐binding protein (FABP4) is abundant in macrophage and adipocyte. It is known to be involved in lipid metabolism. The role of FABP4 has been reported in various cancers, such as non‐small cell lung cancer, breast cancer, ovarian cancer, and prostatic cancer. However, its role rem...
Autores principales: | Zhong, Cheng‐Qian, Zhang, Xiu‐Ping, Ma, Ning, Zhang, Er‐Bin, Li, Jing‐Jing, Jiang, Ya‐Bo, Gao, Yu‐Zhen, Yuan, Yan‐Mei, Lan, Shi‐Qian, Xie, Dong, Cheng, Shu‐Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010697/ https://www.ncbi.nlm.nih.gov/pubmed/29733540 http://dx.doi.org/10.1002/cam4.1511 |
Ejemplares similares
-
Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma
por: Li, Mingxing, et al.
Publicado: (2021) -
Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2014) -
LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma
por: Zhang, Ning, et al.
Publicado: (2022) -
Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma
por: Iida, Noriho, et al.
Publicado: (2019) -
Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2020)